BETA: Please send your feedback!
Celldex Therapeutics
CLDX:NAS
Biotechnology
$0
SMALL cap
$2.20
(-0.04%)
-0.42%
since start of 2019
-0.58
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 1983
Celldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators. The company's drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega. Celldex Therapeutics was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
website
Headquarters
Executives
| Name | Title | Gender |
| Thomas Andrew Davis, MD | Chief Medical Officer & Executive Vice President | Male |
| Avery W. Catlin, MBA, CPA | CFO, Secretary, Treasurer & Senior Vice President | Male |
| Larry Ellberger | Chairman | Male |
| Anthony S. Marucci, MBA | President, Chief Executive Officer & Director | Male |
| Tibor Keler, PhD | Chief Scientific Officer & Executive VP | Male |
| Sarah Boylan Cavanaugh | VP-Investor Relations & Corporate Communications | Female |
| Theresa M. LaVallee, PhD | Senior VP-Regulatory & Precision Medicine | Female |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
Celldex Therapeutics - Competitors and Related Companies
How Celldex Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.
Celldex Therapeutics
CLDX:NAS
Biotechnology
$0
SMALL cap
$2.20
(-0.04%)
-0.42%
since start of 2019
-0.58
Emergent BioSolutions
EBS:NYS
Biotechnology
$2.79bn
MID cap
$54.03
(0.71%)
-0.06%
since start of 2019
691.81
Seattle Genetics
SGEN:NAS
Biotechnology
$19.24bn
MID cap
$112.26
(0.92%)
0.94%
since start of 2019
-60.08
Vical
VICL:NAS
Biotechnology
$15.44mm
MICRO cap
$0.68
(0.00%)
-0.42%
since start of 2019
-1.23
GlaxoSmithKline
GSK-GB:LON
Pharmaceuticals: Major
$113.73bn
MEGA cap
$45.93
(-0.36%)
0.21%
since start of 2019
19.57
Pfizer
PFE:NYS
Pharmaceuticals: Major
$213.28bn
MEGA cap
$38.54
(0.32%)
-0.11%
since start of 2019
13.24